Zika Virus Infection: all 65 studies
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Xpert® Tropical Fever Test on GeneXpert® Edge X SystemEnrolling by invitationNCT07520279
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT07358910
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable
- Neurodevelopmental Outcomes in ZIKV-Exposed ChildrenEnrolling by invitationNCT04398901
- Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsRecruitingNCT01386424
- Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)CompletedNCT05123222Phase 1Results posted
- Adherence to Care for Children With Congenital Zika Virus Infection in Puerto RicoCompletedNCT05041439Not applicableResults posted
- A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus AreasCompletedNCT04917861Phase 2Results posted
- Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne DiseasesCompletedNCT04343521Not applicableResults posted
- Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative AdultsCompletedNCT04064905Phase 1Results posted
- Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001)CompletedNCT04033068Phase 1Results posted
- Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG)CompletedNCT03624946Phase 1Results posted
- Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve AdultsCompletedNCT03611946Phase 1Results posted
- Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy ParticipantsCompletedNCT03343626Phase 1Results posted
- Prospective Cohort Study of HIV and Zika in Infants and PregnancyCompletedNCT03263195Results posted
- VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and AdolescentsCompletedNCT03110770Phase 2Results posted
- Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult SubjectsCompletedNCT03014089Phase 1Results posted
- Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic AreaCompletedNCT03008122Phase 1Results posted
- Using Digital Technology for the Prevention of Aedes-Borne Diseases in Colombian CommunitiesCompletedNCT07517731Not applicable
- Impacts of a Physical Therapy Protocol on Motor Function in Children With Congenital Zika SyndromeCompletedNCT06900322Not applicable
- Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP ChallengeCompletedNCT06805487Phase 1
- Testing Combined IIT-SIT to Control Mosquito-Borne Diseases At ScaleTerminatedNCT06595745Not applicable
- Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy AdultsCompletedNCT06334393Phase 1
- Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental ModelWithdrawnNCT05589012
- A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy AdultsWithdrawnNCT05469802Phase 2
- Spatial Repellents for Aedes-borne Virus Control in Sri LankaCompletedNCT05452447Not applicable
- Zika and Neurodevelopment Among Infants in GrenadaCompletedNCT04697147Not applicable
- A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)CompletedNCT04514107Not applicable
- Safety and Immunogenicity of BBV121CompletedNCT04478656Phase 1
- Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, NicaraguaCompletedNCT04182685
- Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISACompletedNCT03776903
- Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected PatientsWithdrawnNCT03776695Phase 1
- Sensorimotor Outcomes of Children Exposed to Foetal Zika Virus InfectionCompletedNCT03679728
- Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, ColombiaCompletedNCT03631719
- Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in ChildrenCompletedNCT03534245
- Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in HumansCompletedNCT03443830Phase 1
- Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy AdultsCompletedNCT03425149Phase 1
- ZIKAlliance Children Cohort (ZIKAllianceCH)CompletedNCT03393286
- Efficacy of Aquatic Physiotherapy in Children With Microcephaly by Zika Virus Congenital SyndromeCompletedNCT03330600Not applicable
- Vertical Exposure to Zika Virus and Its Consequences for Child Neurodevelopment (ZIKVIRUSIFF)Status unknownNCT03255369
- Dermatologic Manifestations of Zika VirusWithdrawnNCT03229421
- Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus SyndromeStatus unknownNCT03227601Not applicable
- Neurologic Manifestations of the Arbovirus Infection in ColombiaCompletedNCT03206541
- ZIKAlliance Natural History StudyWithdrawnNCT03204409
- ZIKAlliance Pregnant Women CohortCompletedNCT03188731
- Estimated Cumulative Incidence of Zika Infection at the End of the First Epidemic in the French West Indies in a Sample of Patients Followed for HIV Infection.TerminatedNCT03161444Not applicable
- Zika Case Definition and Surveillance StudyCompletedNCT03158233
- Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in BrazilCompletedNCT03106714
- Applying Wolbachia to Eliminate DengueTerminatedNCT03055585Not applicable
- INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsCompletedNCT03037164Phase 3
- Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)CompletedNCT02996890Phase 1
- VRC 320: A Phase I, Randomized Clinical Trial to Evaluate the Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA090-00-VP, Administered Via Needle and Syringe or Needle-free Injector, PharmaJet, inHealthy AdultsCompletedNCT02996461Phase 1
- Understanding Excretion and Infectivity of Zika Virus in Semen During and After InfectionCompletedNCT02979938
- A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.CompletedNCT02963909Phase 1
- ZIKA Vaccine in Naive SubjectsCompletedNCT02952833Phase 1
- Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in UteroCompletedNCT02943304
- Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule StudyCompletedNCT02937233Phase 1
- Pilot Study to Detect Zika Virus in SpermCompletedNCT02874456Not applicable
- Zika in Infants and Pregnancy (ZIP)CompletedNCT02856984
- Safety and Immunogenicity of a Zika Virus DNA Vaccine, VRC-ZKADNA085-00-VP, in Healthy AdultsCompletedNCT02840487Phase 1
- The Evaluation of Potential Zika, Chikungunya, and Dengue Infections in MexicoCompletedNCT02831699
- Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of AmericaCompletedNCT02810210
- Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)CompletedNCT02794181
- Persistence of Zika Virus in Semen After Acute InfectionCompletedNCT02733796
- Cohort of Patients Infected by an ArbovirusStatus unknownNCT01099852